Schott delivers pharma vials to package 2 billion doses of Covid-19 vaccines

Schott supports the world’s fight against Covid -19 with vials capable of holding up to 2 billion vaccination doses. The glassmaker and pharma packaging specialist has reached agreements with leading pharmaceutical companies, including partners of ‘Operation Warp Speed’ – the US government initiative to serve local vaccine production needs. The agreements become effective immediately, and first vials are being delivered to companies in North America, Europe, and Asia. According to the company’s press statement, Schott is ideally positioned to meet the challenging demand situation, as it has been maintaining a global and already validated production network for decades. Even before the expansion, the company already produced more than 11 billion pharma containers for life-saving drugs per annum. Schott invests EUR 350 million “We have invested EUR 350 million (approximately Rs 3000 crore) in recent months”, said chief executive officer Frank Heinricht, “Demand for high-quality pharma packaging has been high before Coronavirus. The fact that we had set up an investment program in 2019 now enables us to ramp up production quickly.” Schott’s 20 production sites…

Choose your subscription to read more